Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,239 total articles
Director Emerita Susan M. Byrne executed a series of share sales in Westwood Holdings Group Inc. (NASDAQ: WHG) during early June 2026, disposing of 3,123 shares through a Rule 10b5-1 trading plan. The transactions occurred as the stock trades near $17.51, reflecting a significant year-over-year gain, while the company recently reported mixed first-…
Sylebra Capital LLC, acting as an investment sub-adviser for Impinj Inc. (NASDAQ: PI) director Daniel Patrick Gibson, executed two separate sales of Impinj common stock totaling $5,890,074 on June 5, 2026. The transactions, which involved the disposal of 47,479 shares at prices ranging from $122.5003 to $128.8684, reduce Sylebra's indirect holding …
Stephen P. Carey, Senior Vice President and Chief Financial Officer at ANI Pharmaceuticals Inc. (NASDAQ:ANIP), executed a series of transactions on June 5, 2026, involving the exercise of stock options and the subsequent sale of 3,312 shares of common stock. The sale was conducted at $80.00 per share, totaling $264,960. These actions were part of a…
Brady Brewer, Starbucks' international chief executive, executed a sale of 1,641 shares under a Rule 10b5-1 plan, bringing his direct holdings to over 80,000 shares. The transaction highlights ongoing corporate activities, including a $1.32 billion note tender offer and strategic shifts in compensation tied to AI adoption, set against a backdrop of…
An entity tied to Dell Technologies Inc. director Egon Durban executed a significant divestiture of Class C Common Stock, marking a notable shift in insider positioning. The transaction occurred against a backdrop of recent market volatility and strong fiscal performance, highlighting the complex interplay between executive strategy and corporate v…
Silver Lake Technology Investors IV, L.P., an affiliate of the prominent private equity firm Silver Lake Group, L.L.C., executed a significant transaction involving Dell Technologies Inc. (NYSE:DELL) equity on June 5, 2026. The entity sold 1,401 shares of Class C Common Stock, realizing proceeds totaling $563,804. The transaction was facilitated th…
Sunrun Inc. (NASDAQ: RUN) CFO Danny Abajian sold 2,030 shares on June 8, 2026, for $27,189 to cover tax obligations from vested restricted stock units. The transaction occurred as the stock declined 17% over the past week despite a 52% annual return. Abajian also managed indirect holdings through a family trust. Sunrun recently reported Q1 2026 EPS…
George W. Cummings III, a director at Business First Bancshares, Inc. (NASDAQ: BFST), executed a sale of 15,000 shares of the company's common stock on June 8, 2026. The transaction was completed at a price of $28.54 per share, resulting in a total value of approximately $428,100. This sale brings Mr. Cummings' direct holdings to 281,180 shares, wh…
Andrew Kang, Strategy Inc.'s Executive Vice President and Chief Financial Officer, executed a sale of 1,949 shares of the company's Class A Common Stock on June 9, 2026. The transaction, valued at $241,362, was conducted through a Rule 10b5-1 trading plan established in May 2024. The primary objective of the sale was to fulfill tax withholding requ…
Le Phong, President and CEO of Strategy Inc (NASDAQ:MSTR), executed a series of share sales totaling $683,838 on June 9, 2026, through a Rule 10b5-1 trading plan established in May 2024. The transactions were designed to cover tax withholding obligations stemming from the vesting and settlement of restricted stock units. Concurrently, strategic adj…
Silver Lake Group, L.L.C. and its affiliated entities, including Dell Technologies Inc. (NASDAQ:DELL) director Egon Durban, executed the sale of 36,736 shares of Dell Technologies Class C Common Stock on June 5, 2026. The transactions, valued at approximately $14.8 million, occurred within a price range of $395.39 to $412.35. This activity coincide…
Uri Clinton, Chief Legal Officer and Secretary of Boyd Gaming Corp. (NASDAQ: BYD), executed a sale of 3,468 shares on June 9, 2026, valued at $304,108. The transaction occurred at $87.69 per share, leaving Clinton with a direct holding of 56,818 shares. This insider activity coincides with the company trading near its 52-week high of $89.96, despit…
Thomas M. Constantine, Executive Vice President and Chief Credit Officer at Axos Financial, Inc. (NASDAQ: AX), executed a sale of 1,994 shares of the company's common stock on June 8, 2026. The transaction, valued at $176,574, occurred at prices ranging from $88.19 to $90.00 per share, with a weighted average price of $88.553. This sale brings Cons…
Crocs, Inc. (NASDAQ:CROX) Chief Executive Officer Andrew Rees executed a significant divestment of company equity, selling approximately $3.86 million worth of common stock on June 5, 2026. The transaction was facilitated through the REES FAMILY LIVING TRUST, which Rees manages as a trustee. The sale occurs against a backdrop of substantial share p…
United Therapeutics Corp (NASDAQ:UTHR) Chief Financial Officer and Treasurer James Edgemond executed a transaction involving the sale of 10,000 shares of the company's common stock on June 8, 2026. The sale, valued at approximately $5.48 million, was conducted pursuant to a pre-arranged Rule 10b5-1 trading plan established on October 31, 2025. Prio…
Charles Thomas McMillen, a director at Nexstar Media Group, Inc., executed a sale of 1,000 shares on June 9, 2026, totaling $180,000. This transaction occurred as the company's stock traded slightly above the sale price, reflecting a valuation metric that some analysts view as high relative to fair value. The sale comes shortly after Nexstar report…
Elite Health Systems Inc. CEO and director jeereddi Prasad Anjaneya has increased his stake in the company through two separate transactions totaling $12,600. The purchases, disclosed via SEC Form 4 filings, occurred at a consistent price point despite recent downward price action. This activity follows a period of significant market depreciation f…
Immunome Inc. (NASDAQ:IMNM) director Jean Jacques Bienaime executed a series of matched open-market transactions on June 5, 2026, involving the sale and subsequent reacquisition of 10,500 shares each. The simultaneous nature of these trades, which generated a minor short-swing profit, occurs against a backdrop of significant clinical and regulatory…
Stephen A. Sherwin, a director at Neurocrine Biosciences Inc. (NASDAQ: NBIX), executed a transaction involving the sale of 25,000 shares of common stock on June 5, 2026, generating approximately $4.13 million. The sale was conducted under a Rule 10b5-1 trading plan established earlier in the year. The transaction coincides with the stock trading ne…
Alset Inc., a significant shareholder in HWH International Inc., has executed a direct purchase of 250,000 newly issued shares of HWH International common stock. The transaction, valued at $500,000, occurs against a backdrop of HWH International's ongoing challenges with Nasdaq listing compliance. While the purchase price represents a substantial p…
Taira Thomas, President of Special Projects at CARVANA CO. (NASDAQ:CVNA), executed a sale of 5,597 shares of Class A Common Stock on June 8, 2026. The transaction, valued at $375,838, was conducted at $67.15 per share under a Rule 10b5-1 trading plan established in August 2025. Following the sale, Thomas retains a direct holding of 315,075 shares. …
Malik Fady Ibraham, Executive Vice President of Research & Development at Cytokinetics Incorporated (NASDAQ:CYTK), executed a series of equity transactions on June 9, 2026. The executive sold 3,500 shares for $237,930 following the exercise of non-qualified stock options. This activity occurs as Cytokinetics advances its cardiac myosin inhibitor, M…
Nina Capital Holdings Inc., a ten percent owner of PetMed Express Inc. (NASDAQ:PETS), has purchased an additional $43,725 worth of common stock. The acquisition occurred on June 8, 2026, involving 25,000 shares at a weighted average price of $1.749 per share. This purchase comes as the stock has experienced substantial declines over recent periods,…
BioCardia Inc. (NASDAQ: BCDA) President and CEO Peter Altman executed a stock purchase on June 9, 2026, acquiring 5,000 shares at $0.85 per share, totaling $4,250. This transaction occurred just above the stock's 52-week low of $0.84 and follows a period where the share price has declined 59% over the past year. Following the purchase, Altman's dir…
Matthew J. Cox, the Chairman and Chief Executive Officer of Matson, Inc., has executed a significant sale of company shares, offloading 9,900 shares on June 8, 2026. The transaction, valued at approximately $1.9 million, was conducted under a Rule 10b5-1 trading plan established in March of the same year. This executive activity coincides with Mats…
